Health Canada drug identification number

DIN 02314304 — TEVA-NARATRIPTAN 2.5 MG

TEVA-NARATRIPTAN is a tablet of Naratriptan marketed by TEVA CANADA LIMITED. The full Naratriptan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02314304
Brand name
TEVA-NARATRIPTAN
Active ingredient
Naratriptan
Strength
2.5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Selective serotonin 5-HT1B/1D receptor agonist (triptan)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Naratriptan products

DINBrandStrengthFormManufacturerStatus
02322323 SANDOZ NARATRIPTAN 2.5 MG TABLET SANDOZ CANADA INCORPORATED MARKETED
02314290 TEVA-NARATRIPTAN 1 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.